(-)-epigallocatechin 3-gallate multiple interactions ISO SLC39A10 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SLC39A10 mRNA CTD PMID:22079256 1,2-dimethylhydrazine multiple interactions EXP 6480464 [APC protein affects the susceptibility to 1 and 2-Dimethylhydrazine] which results in increased expression of SLC39A10 mRNA CTD PMID:27840820 1,3-dicyclohexylcarbodiimide multiple interactions EXP 6480464 Dicyclohexylcarbodiimide inhibits the reaction [SLC39A10 protein results in increased uptake of Zinc] CTD PMID:16804107 1-benzylpiperazine increases expression EXP 6480464 N-benzylpiperazine results in increased expression of SLC39A10 mRNA CTD PMID:26821219 17beta-estradiol decreases expression ISO SLC39A10 (Homo sapiens) 6480464 Estradiol results in decreased expression of SLC39A10 mRNA CTD PMID:20106945 and PMID:21632981 17beta-estradiol multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of SLC39A10 mRNA CTD PMID:32741896 17beta-estradiol multiple interactions ISO SLC39A10 (Homo sapiens) 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of SLC39A10 mRNA CTD PMID:30165855 17beta-estradiol 3-benzoate decreases expression EXP 6480464 estradiol 3-benzoate results in decreased expression of SLC39A10 mRNA CTD PMID:32741896 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of SLC39A10 mRNA CTD PMID:32741896 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO SLC39A10 (Homo sapiens) 6480464 Dihydrotestosterone results in increased expression of SLC39A10 mRNA CTD PMID:29581250 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO Slc39a10 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO Slc39a10 (Mus musculus) 6480464 2 more ... CTD PMID:30294300 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO Slc39a10 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO SLC39A10 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC39A10 mRNA CTD PMID:20106945 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC39A10 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Slc39a10 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of SLC39A10 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC39A10 mRNA CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Slc39a10 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC39A10 mRNA CTD PMID:21354282 2-methylcholine affects expression ISO SLC39A10 (Homo sapiens) 6480464 beta-methylcholine affects the expression of SLC39A10 mRNA CTD PMID:21179406 3,4-methylenedioxymethamphetamine decreases expression ISO Slc39a10 (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of SLC39A10 mRNA CTD PMID:26251327 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of SLC39A10 mRNA CTD PMID:30047161 acetamide increases expression EXP 6480464 acetamide results in increased expression of SLC39A10 mRNA CTD PMID:31881176 acrolein multiple interactions ISO SLC39A10 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SLC39A10 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of SLC39A10 mRNA CTD PMID:32699268 acrylamide increases expression ISO Slc39a10 (Mus musculus) 6480464 Acrylamide results in increased expression of SLC39A10 mRNA CTD PMID:30807115 actinomycin D multiple interactions ISO Slc39a10 (Mus musculus) 6480464 Dactinomycin inhibits the reaction [N more ... CTD PMID:21738690 aflatoxin B1 affects expression ISO SLC39A10 (Homo sapiens) 6480464 Aflatoxin B1 affects the expression of SLC39A10 protein CTD PMID:20106945 aflatoxin B1 increases expression ISO SLC39A10 (Homo sapiens) 6480464 Aflatoxin B1 results in increased expression of SLC39A10 mRNA CTD PMID:27153756 all-trans-retinoic acid decreases expression ISO SLC39A10 (Homo sapiens) 6480464 Tretinoin results in decreased expression of SLC39A10 mRNA CTD PMID:33167477 alpha-pinene multiple interactions ISO SLC39A10 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SLC39A10 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of SLC39A10 mRNA CTD PMID:32699268 amitrole increases expression EXP 6480464 Amitrole results in increased expression of SLC39A10 mRNA CTD PMID:30047161 Aroclor 1254 decreases expression ISO Slc39a10 (Mus musculus) 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of SLC39A10 mRNA CTD PMID:23650126 arsenite(3-) multiple interactions ISO SLC39A10 (Homo sapiens) 6480464 arsenite inhibits the reaction [G3BP1 protein binds to SLC39A10 mRNA] CTD PMID:32406909 arsenous acid decreases expression ISO SLC39A10 (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of SLC39A10 mRNA CTD PMID:27829220 atrazine decreases expression EXP 6480464 Atrazine results in decreased expression of SLC39A10 mRNA CTD PMID:36841081 benzo[a]pyrene increases expression ISO SLC39A10 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of SLC39A10 mRNA CTD PMID:20106945 and PMID:32234424 benzo[a]pyrene affects methylation ISO SLC39A10 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of SLC39A10 promoter CTD PMID:27901495 bisphenol A decreases expression ISO Slc39a10 (Mus musculus) 6480464 bisphenol A results in decreased expression of SLC39A10 mRNA CTD PMID:26063408 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of SLC39A10 mRNA CTD PMID:32145629 bisphenol A decreases expression ISO SLC39A10 (Homo sapiens) 6480464 bisphenol A results in decreased expression of SLC39A10 mRNA and bisphenol A results in decreased expression of SLC39A10 protein CTD PMID:29275510 and PMID:33376534 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SLC39A10 mRNA CTD PMID:25181051 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Testosterone] results in increased expression of SLC39A10 mRNA CTD PMID:26496021 cadmium atom multiple interactions EXP 6480464 Cadmium inhibits the reaction [SLC39A10 protein results in increased uptake of Zinc] CTD PMID:16804107 cadmium atom multiple interactions ISO Slc39a10 (Mus musculus) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLC39A10 mRNA CTD PMID:37325564 cadmium atom multiple interactions ISO SLC39A10 (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SLC39A10 mRNA CTD PMID:31738976 cadmium dichloride affects expression EXP 6480464 Cadmium Chloride affects the expression of SLC39A10 mRNA CTD PMID:22110744 cadmium dichloride multiple interactions ISO Slc39a10 (Mus musculus) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLC39A10 mRNA CTD PMID:37325564 cadmium dichloride multiple interactions ISO SLC39A10 (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SLC39A10 mRNA CTD PMID:31738976 cadmium sulfate multiple interactions ISO Slc39a10 (Mus musculus) 6480464 cadmium sulfate affects the reaction [MTF1 affects the expression of SLC39A10 mRNA] CTD PMID:16221973 calcitriol decreases expression ISO SLC39A10 (Homo sapiens) 6480464 Calcitriol results in decreased expression of SLC39A10 mRNA CTD PMID:20089671 cannabidiol decreases expression ISO Slc39a10 (Mus musculus) 6480464 Cannabidiol results in decreased expression of SLC39A10 mRNA CTD PMID:21542829 and PMID:22178458 carbamazepine affects expression ISO SLC39A10 (Homo sapiens) 6480464 Carbamazepine affects the expression of SLC39A10 mRNA CTD PMID:25979313 carbon nanotube increases expression ISO Slc39a10 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 CGP 52608 multiple interactions ISO SLC39A10 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to SLC39A10 gene] CTD PMID:28238834 chlorpyrifos decreases expression ISO Slc39a10 (Mus musculus) 6480464 Chlorpyrifos results in decreased expression of SLC39A10 mRNA CTD PMID:37019170 cisplatin decreases expression ISO SLC39A10 (Homo sapiens) 6480464 Cisplatin results in decreased expression of SLC39A10 mRNA CTD PMID:27594783 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of SLC39A10 mRNA CTD PMID:24386269 cocaine decreases expression EXP 6480464 Cocaine results in decreased expression of SLC39A10 mRNA CTD PMID:17898221 coumarin increases phosphorylation ISO SLC39A10 (Homo sapiens) 6480464 coumarin results in increased phosphorylation of SLC39A10 protein CTD PMID:35688186 cyclosporin A decreases expression ISO SLC39A10 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of SLC39A10 mRNA CTD PMID:20106945 more ... dextran sulfate multiple interactions ISO Slc39a10 (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SLC39A10 mRNA CTD PMID:29950665 diarsenic trioxide decreases expression ISO SLC39A10 (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of SLC39A10 mRNA CTD PMID:27829220 dicrotophos decreases expression ISO SLC39A10 (Homo sapiens) 6480464 dicrotophos results in decreased expression of SLC39A10 mRNA CTD PMID:28302478 dorsomorphin multiple interactions ISO SLC39A10 (Homo sapiens) 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin increases expression ISO SLC39A10 (Homo sapiens) 6480464 Doxorubicin results in increased expression of SLC39A10 mRNA CTD PMID:29803840 enzyme inhibitor multiple interactions ISO SLC39A10 (Homo sapiens) 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of SLC39A10 protein CTD PMID:23301498 ethanol multiple interactions ISO Slc39a10 (Mus musculus) 6480464 Ethanol affects the expression of and affects the splicing of SLC39A10 mRNA CTD PMID:30319688 ethyl methanesulfonate decreases expression ISO SLC39A10 (Homo sapiens) 6480464 Ethyl Methanesulfonate results in decreased expression of SLC39A10 mRNA CTD PMID:23649840 flusilazole decreases expression EXP 6480464 flusilazole results in decreased expression of SLC39A10 mRNA CTD PMID:28263823 FR900359 affects phosphorylation ISO SLC39A10 (Homo sapiens) 6480464 FR900359 affects the phosphorylation of SLC39A10 protein CTD PMID:37730182 gadodiamide hydrate increases expression ISO SLC39A10 (Homo sapiens) 6480464 gadodiamide results in increased expression of SLC39A10 mRNA CTD PMID:20959327 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of SLC39A10 mRNA CTD PMID:22061828 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of SLC39A10 mRNA CTD PMID:33387578 hydrogen peroxide affects expression ISO SLC39A10 (Homo sapiens) 6480464 Hydrogen Peroxide affects the expression of SLC39A10 mRNA CTD PMID:20044591 inulin multiple interactions ISO Slc39a10 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of SLC39A10 mRNA CTD PMID:36331819 ivermectin decreases expression ISO SLC39A10 (Homo sapiens) 6480464 Ivermectin results in decreased expression of SLC39A10 protein CTD PMID:32959892 lead diacetate decreases expression ISO Slc39a10 (Mus musculus) 6480464 lead acetate results in decreased expression of SLC39A10 mRNA CTD PMID:25270620 lipopolysaccharide decreases expression ISO Slc39a10 (Mus musculus) 6480464 Lipopolysaccharides results in decreased expression of SLC39A10 mRNA and Lipopolysaccharides results in decreased expression of SLC39A10 protein CTD PMID:16892068 and PMID:17126599 lipopolysaccharide multiple interactions ISO Slc39a10 (Mus musculus) 6480464 TICAM1 protein affects the reaction [Lipopolysaccharides results in decreased expression of SLC39A10 protein] CTD PMID:16892068 mercaptoethanol multiple interactions EXP 6480464 Mercaptoethanol inhibits the reaction [SLC39A10 protein results in increased uptake of Zinc] CTD PMID:16804107 methimazole increases expression EXP 6480464 Methimazole results in increased expression of SLC39A10 mRNA CTD PMID:30047161 methotrexate affects expression ISO Slc39a10 (Mus musculus) 6480464 Methotrexate affects the expression of SLC39A10 mRNA CTD PMID:18502557 methoxychlor affects methylation EXP 6480464 Methoxychlor affects the methylation of SLC39A10 gene CTD PMID:35440735 methyl methanesulfonate decreases expression ISO SLC39A10 (Homo sapiens) 6480464 Methyl Methanesulfonate results in decreased expression of SLC39A10 mRNA CTD PMID:23649840 motexafin gadolinium multiple interactions ISO SLC39A10 (Homo sapiens) 6480464 [Zinc Acetate co-treated with motexafin gadolinium] affects the expression of SLC39A10 mRNA CTD PMID:16357179 motexafin gadolinium affects expression ISO SLC39A10 (Homo sapiens) 6480464 motexafin gadolinium affects the expression of SLC39A10 mRNA CTD PMID:16357179 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine increases expression ISO Slc39a10 (Mus musculus) 6480464 N more ... CTD PMID:21738690 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine multiple interactions ISO Slc39a10 (Mus musculus) 6480464 Dactinomycin inhibits the reaction [N more ... CTD PMID:21738690 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine multiple interactions ISO SLC39A10 (Homo sapiens) 6480464 [ochratoxin A co-treated with N more ... CTD PMID:19720134 nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of SLC39A10 mRNA CTD PMID:22110744 ochratoxin A multiple interactions ISO SLC39A10 (Homo sapiens) 6480464 [ochratoxin A co-treated with N more ... CTD PMID:19720134 ozone multiple interactions ISO SLC39A10 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SLC39A10 mRNA more ... CTD PMID:32699268 and PMID:35430440 ozone multiple interactions ISO Slc39a10 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of Ozone] which results in increased expression of SLC39A10 mRNA CTD PMID:34911549 p-chloromercuribenzoic acid decreases expression ISO SLC39A10 (Homo sapiens) 6480464 p-Chloromercuribenzoic Acid results in decreased expression of SLC39A10 mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO SLC39A10 (Homo sapiens) 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC39A10 mRNA CTD PMID:27188386 paracetamol increases expression ISO SLC39A10 (Homo sapiens) 6480464 Acetaminophen results in increased expression of SLC39A10 mRNA CTD PMID:29067470 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of SLC39A10 mRNA CTD PMID:33387578 PCB138 multiple interactions ISO Slc39a10 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 pentetic acid increases expression ISO Slc39a10 (Mus musculus) 6480464 Pentetic Acid results in increased expression of SLC39A10 mRNA and Pentetic Acid results in increased expression of SLC39A10 protein CTD PMID:21738690 perfluorooctane-1-sulfonic acid decreases expression ISO SLC39A10 (Homo sapiens) 6480464 perfluorooctane sulfonic acid results in decreased expression of SLC39A10 mRNA CTD PMID:27153767 perfluorooctane-1-sulfonic acid multiple interactions ISO Slc39a10 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of SLC39A10 mRNA and [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of SLC39A10 mRNA CTD PMID:36331819 phenobarbital affects expression ISO Slc39a10 (Mus musculus) 6480464 Phenobarbital affects the expression of SLC39A10 mRNA CTD PMID:23091169 phenylmercury acetate decreases expression ISO SLC39A10 (Homo sapiens) 6480464 Phenylmercuric Acetate results in decreased expression of SLC39A10 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO SLC39A10 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC39A10 mRNA CTD PMID:27188386 potassium chromate decreases expression ISO SLC39A10 (Homo sapiens) 6480464 potassium chromate(VI) results in decreased expression of SLC39A10 mRNA CTD PMID:22079256 potassium chromate multiple interactions ISO SLC39A10 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SLC39A10 mRNA CTD PMID:22079256 quercetin increases expression ISO SLC39A10 (Homo sapiens) 6480464 Quercetin results in increased expression of SLC39A10 mRNA CTD PMID:21632981 rimonabant multiple interactions ISO Slc39a10 (Mus musculus) 6480464 Rimonabant inhibits the reaction [Dietary Fats results in increased expression of SLC39A10 mRNA] CTD PMID:19030233 SB 431542 multiple interactions ISO SLC39A10 (Homo sapiens) 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide increases expression ISO SLC39A10 (Homo sapiens) 6480464 Silicon Dioxide analog results in increased expression of SLC39A10 mRNA CTD PMID:25895662 silver atom decreases expression ISO SLC39A10 (Homo sapiens) 6480464 Silver results in decreased expression of SLC39A10 mRNA CTD PMID:26014281 silver(0) decreases expression ISO SLC39A10 (Homo sapiens) 6480464 Silver results in decreased expression of SLC39A10 mRNA CTD PMID:26014281 sodium arsenite decreases expression ISO Slc39a10 (Mus musculus) 6480464 sodium arsenite results in decreased expression of SLC39A10 mRNA CTD PMID:37682722 sulfadimethoxine increases expression EXP 6480464 Sulfadimethoxine results in increased expression of SLC39A10 mRNA CTD PMID:30047161 tebufenpyrad decreases expression ISO SLC39A10 (Homo sapiens) 6480464 4-chloro-N-((4-(1 and 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in decreased expression of SLC39A10 mRNA CTD PMID:33512557 temozolomide decreases expression ISO SLC39A10 (Homo sapiens) 6480464 Temozolomide results in decreased expression of SLC39A10 mRNA CTD PMID:31758290 testosterone multiple interactions EXP 6480464 [bisphenol A co-treated with Testosterone] results in increased expression of SLC39A10 mRNA and [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of SLC39A10 mRNA CTD PMID:26496021 and PMID:32741896 tetrachloromethane increases expression ISO Slc39a10 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of SLC39A10 mRNA CTD PMID:31919559 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of SLC39A10 mRNA CTD PMID:23411599 and PMID:34492290 titanium dioxide multiple interactions ISO Slc39a10 (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SLC39A10 mRNA CTD PMID:29950665 triptonide decreases expression ISO Slc39a10 (Mus musculus) 6480464 triptonide results in decreased expression of SLC39A10 mRNA CTD PMID:33045310 valdecoxib increases expression EXP 6480464 valdecoxib results in increased expression of SLC39A10 mRNA CTD PMID:24136188 valproic acid decreases methylation ISO SLC39A10 (Homo sapiens) 6480464 Valproic Acid results in decreased methylation of SLC39A10 gene CTD PMID:29154799 valproic acid affects splicing EXP 6480464 Valproic Acid affects the splicing of SLC39A10 mRNA CTD PMID:29427782 valproic acid affects expression ISO SLC39A10 (Homo sapiens) 6480464 Valproic Acid affects the expression of SLC39A10 mRNA CTD PMID:25979313 valproic acid decreases expression ISO SLC39A10 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of SLC39A10 mRNA CTD PMID:23179753 valproic acid affects expression ISO Slc39a10 (Mus musculus) 6480464 Valproic Acid affects the expression of SLC39A10 mRNA CTD PMID:17292431 zidovudine decreases expression ISO SLC39A10 (Homo sapiens) 6480464 Zidovudine results in decreased expression of SLC39A10 mRNA CTD PMID:24292225 zinc acetate affects expression ISO SLC39A10 (Homo sapiens) 6480464 Zinc Acetate affects the expression of SLC39A10 mRNA CTD PMID:16357179 zinc acetate multiple interactions ISO SLC39A10 (Homo sapiens) 6480464 [Zinc Acetate co-treated with motexafin gadolinium] affects the expression of SLC39A10 mRNA CTD PMID:16357179 zinc atom increases expression ISO Slc39a10 (Mus musculus) 6480464 Zinc deficiency results in increased expression of SLC39A10 mRNA and Zinc deficiency results in increased expression of SLC39A10 protein CTD PMID:18936201 more ... zinc atom decreases expression ISO Slc39a10 (Mus musculus) 6480464 Zinc results in decreased expression of SLC39A10 mRNA CTD PMID:21738690 zinc atom multiple interactions ISO Slc39a10 (Mus musculus) 6480464 MTF1 mutant form inhibits the reaction [Zinc results in decreased expression of SLC39A10 mRNA] more ... CTD PMID:21738690 zinc atom multiple interactions ISO SLC39A10 (Homo sapiens) 6480464 [ochratoxin A co-treated with N more ... CTD PMID:18593933 and PMID:19720134 zinc atom increases expression EXP 6480464 Zinc results in increased expression of SLC39A10 mRNA and Zinc results in increased expression of SLC39A10 protein CTD PMID:16804107 zinc atom increases uptake EXP 6480464 SLC39A10 protein results in increased uptake of Zinc CTD PMID:16804107 zinc atom decreases expression EXP 6480464 Zinc results in decreased expression of SLC39A10 mRNA and Zinc results in decreased expression of SLC39A10 protein CTD PMID:16804107 zinc atom multiple interactions EXP 6480464 Cadmium inhibits the reaction [SLC39A10 protein results in increased uptake of Zinc] more ... CTD PMID:16804107 zinc atom increases transport ISO SLC39A10 (Homo sapiens) 6480464 SLC39A10 protein results in increased transport of Zinc CTD PMID:18326752 zinc sulfate decreases expression EXP 6480464 Zinc Sulfate results in decreased expression of SLC39A10 mRNA and Zinc Sulfate results in decreased expression of SLC39A10 protein CTD PMID:16804107 zinc sulfate increases expression EXP 6480464 Zinc Sulfate results in increased expression of SLC39A10 mRNA and Zinc Sulfate results in increased expression of SLC39A10 protein CTD PMID:16804107 zinc(0) increases expression ISO Slc39a10 (Mus musculus) 6480464 Zinc deficiency results in increased expression of SLC39A10 mRNA and Zinc deficiency results in increased expression of SLC39A10 protein CTD PMID:18936201 more ... zinc(0) increases transport ISO SLC39A10 (Homo sapiens) 6480464 SLC39A10 protein results in increased transport of Zinc CTD PMID:18326752 zinc(0) multiple interactions EXP 6480464 Cadmium inhibits the reaction [SLC39A10 protein results in increased uptake of Zinc] more ... CTD PMID:16804107 zinc(0) decreases expression EXP 6480464 Zinc results in decreased expression of SLC39A10 mRNA and Zinc results in decreased expression of SLC39A10 protein CTD PMID:16804107 zinc(0) increases uptake EXP 6480464 SLC39A10 protein results in increased uptake of Zinc CTD PMID:16804107 zinc(0) increases expression EXP 6480464 Zinc results in increased expression of SLC39A10 mRNA and Zinc results in increased expression of SLC39A10 protein CTD PMID:16804107 zinc(0) multiple interactions ISO SLC39A10 (Homo sapiens) 6480464 [ochratoxin A co-treated with N more ... CTD PMID:18593933 and PMID:19720134 zinc(0) multiple interactions ISO Slc39a10 (Mus musculus) 6480464 MTF1 mutant form inhibits the reaction [Zinc results in decreased expression of SLC39A10 mRNA] more ... CTD PMID:21738690 zinc(0) decreases expression ISO Slc39a10 (Mus musculus) 6480464 Zinc results in decreased expression of SLC39A10 mRNA CTD PMID:21738690 zoledronic acid decreases expression ISO SLC39A10 (Homo sapiens) 6480464 zoledronic acid results in decreased expression of SLC39A10 mRNA CTD PMID:24714768
